Arthritis Research & Therapy

official impact factor 4.36

Antiphospholipid syndrome

Gerard Espinosa and Ricard Cervera*

Arthritis Research & Therapy 2008, 10:230 doi:10.1186/ar2536

Accesses  

  • Last 30 days: 71 accesses
  • Last 365 days: 723 accesses
  • All time: 4069 accesses